Riva-Alendronate Fc 70 mg (Alendronic Acid (Alendronate Sodium) TABLET) 70 MG

RIVA-ALENDRONATE FC 70 MG tablets contain alendronic acid, a medication used to treat osteoporosis and improve bone density. This oral tablet is manufactured by Laboratoire Riva Inc. in Canada.

Strength

70 MG

Pack Size

4/50

Manufacturer / TM Owner

LABORATOIRE RIVA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

RIVA-ALENDRONATE FC 70 MG is primarily used to treat osteoporosis in postmenopausal women and to increase bone mass in men with osteoporosis. Alendronic acid works by slowing bone loss, helping to maintain bone strength and reduce the risk of fractures. This medication is often prescribed for individuals who are at high risk of bone fractures due to low bone density.

Side Effects

Common effects of RIVA-ALENDRONATE FC 70 MG may include mild stomach upset, heartburn, or acid reflux. Some users might experience muscle pain, headache, or dizziness. Severe side effects are rare but can include difficulty swallowing, new or worsening heartburn, or jaw problems. Always consult a healthcare provider if you experience any unusual symptoms.

Precautions & Warnings

RIVA-ALENDRONATE FC 70 MG should be taken with a full glass of water, and you should remain upright for at least 30 minutes after taking the tablet to prevent irritation. Do not lie down or consume food, beverages, or other medications for at least 30 minutes after taking this medication. Individuals with low calcium levels, kidney problems, or difficulty swallowing should use this medication with caution.

Avoid Interactions

RIVA-ALENDRONATE FC 70 MG may interact with certain medications, including antacids, aspirin, and other nonsteroidal anti-inflammatory drugs (NSAIDs). Alcohol consumption should be limited, as it can increase the risk of stomach irritation. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.

Frequently Asked Questions

RIVA-ALENDRONATE FC 70 MG is used to treat osteoporosis and improve bone density in both men and women.

Take RIVA-ALENDRONATE FC 70 MG with a full glass of water and remain upright for at least 30 minutes after taking the tablet.

Common side effects may include mild stomach upset, heartburn, muscle pain, headache, or dizziness.

RIVA-ALENDRONATE FC 70 MG may interact with certain medications, so always consult your healthcare provider before combining it with other drugs.

Individuals with low calcium levels, kidney problems, or difficulty swallowing should use this medication with caution.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.